TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 1 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,890 | +1177.0% | 598,000 | +166.5% | 0.00% | – |
| Q2 2023 | $148 | -25.6% | 224,400 | -10.1% | 0.00% | – |
| Q1 2023 | $199 | -83.1% | 249,600 | -52.0% | 0.00% | -100.0% |
| Q4 2022 | $1,175 | -99.9% | 519,800 | +24.2% | 0.00% | +100.0% |
| Q3 2022 | $808,000 | -58.5% | 418,500 | -20.1% | 0.00% | -50.0% |
| Q2 2022 | $1,948,000 | +19.3% | 523,600 | +109.0% | 0.00% | 0.0% |
| Q1 2022 | $1,633,000 | – | 250,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,000,000 | $53,080,000 | 57.48% |
| Octagon Capital Advisors LP | 320,440 | $8,504,000 | 2.95% |
| Alphabet Inc. | 640,882 | $17,009,000 | 0.82% |
| Casdin Capital, LLC | 820,440 | $21,774,000 | 0.64% |
| Artal Group S.A. | 1,040,882 | $27,625,000 | 0.59% |
| VR Adviser, LLC | 107,982 | $2,866,000 | 0.42% |
| Avidity Partners Management LP | 392,000 | $10,404,000 | 0.34% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $13,270,000 | 0.28% |
| Perceptive Advisors | 470,440 | $12,485,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 250,000 | $6,635,000 | 0.13% |